» Articles » PMID: 33869660

Exosomes in the Pathogenesis, Diagnosis and Treatment of Pancreatic Diseases

Overview
Date 2021 Apr 19
PMID 33869660
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes (EXOs) are small vesicles (30-200 nm) of endocytic origin, which are released by many different cell types into the extracellular space. They may play a key role in facilitating cell-cell communication, under both physiological and pathological conditions. EXOs contain a wide range of RNA molecules and proteins. Their specific molecular signatures make them promising candidates in early diagnosis and prognosis of pancreatic diseases. EXOs could also provide a new method to monitor treatment response in patients suffering from pancreatic cancer and other diseases of the pancreas. Additionally they may help to improve current treatments via personalized medicine approaches using them as therapeutic vehicles themselves.

Citing Articles

Highly Pluripotent Adipose-Derived Stem Cell-Enriched Nanofat: A Novel Translational System in Stem Cell Therapy.

Sierra L, Biswas R, Conti A, Busato A, Ossanna R, Zingaretti N Cell Transplant. 2023; 32:9636897231175968.

PMID: 37243545 PMC: 10226300. DOI: 10.1177/09636897231175968.


Exosome Structures Supported by Machine Learning Can Be Used as a Promising Diagnostic Tool.

Mutlu E, Kaya M, Kucuk I, Ben-Nissan B, Stamboulis A Materials (Basel). 2022; 15(22).

PMID: 36431454 PMC: 9693854. DOI: 10.3390/ma15227967.


Application of exosomes in the diagnosis and treatment of pancreatic diseases.

Han L, Zhao Z, Yang K, Xin M, Zhou L, Chen S Stem Cell Res Ther. 2022; 13(1):153.

PMID: 35395948 PMC: 8994331. DOI: 10.1186/s13287-022-02826-y.


Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Zazzeroni L, Lanzoni G, Pasquinelli G, Ricordi C CellR4 Repair Replace Regen Reprogram. 2018; 5(5).

PMID: 30505879 PMC: 6267851.


New insights in the composition of extracellular vesicles from pancreatic cancer cells: implications for biomarkers and functions.

Klein-Scory S, Tehrani M, Eilert-Micus C, Adamczyk K, Wojtalewicz N, Schnolzer M Proteome Sci. 2014; 12(1):50.

PMID: 25469109 PMC: 4251850. DOI: 10.1186/s12953-014-0050-5.

References
1.
Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

2.
Ruffner M, Robbins P . Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice. PLoS One. 2010; 5(7):e11848. PMC: 2912295. DOI: 10.1371/journal.pone.0011848. View

3.
Lee H, Han K, Lee S, Kim S, Kang H, Cheong H . Urinary exosomal WT1 in childhood nephrotic syndrome. Pediatr Nephrol. 2011; 27(2):317-20. DOI: 10.1007/s00467-011-2035-2. View

4.
Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R . Diabetes mellitus, a microRNA-related disease?. Transl Res. 2011; 157(4):253-64. DOI: 10.1016/j.trsl.2011.01.009. View

5.
Ferrara A, Kahn H, Quesenberry C, Riley C, Hedderson M . An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol. 2004; 103(3):526-33. DOI: 10.1097/01.AOG.0000113623.18286.20. View